These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8889731)
1. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest. Biedenbach D; Wanger A; Jones RN J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731 [No Abstract] [Full Text] [Related]
2. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae. Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271 [TBL] [Abstract][Full Text] [Related]
3. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. Pantosti A; D'Ambrosio F; Bordi E; Scotto D'Abusco A; Del Grosso M Clin Microbiol Infect; 2001 Sep; 7(9):503-6. PubMed ID: 11678935 [TBL] [Abstract][Full Text] [Related]
4. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Barry AL; Fuchs PC; Brown SD Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816 [TBL] [Abstract][Full Text] [Related]
5. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Pankuch GA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583 [TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae. Lozniewski A; Lion C; Mory F; Weber M Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841 [TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic sensitivity pattern of recent clinical isolates of Streptococcus pneumoniae. Zackrisson G; Brorson JE Acta Pathol Microbiol Scand B; 1981 Feb; 89(1):25-8. PubMed ID: 6910980 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591 [TBL] [Abstract][Full Text] [Related]
11. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients. Obert CA; Miller ML; Montgomery J; Adamkiewicz T; Tuomanen EI Antimicrob Agents Chemother; 2007 Jan; 51(1):386-9. PubMed ID: 17060526 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Visalli MA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375 [TBL] [Abstract][Full Text] [Related]
13. [Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou]. Hua CZ; Shang SQ; Sun XF; Li JP; Chen ZM; Yu XL Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):16-9. PubMed ID: 14990098 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198 [TBL] [Abstract][Full Text] [Related]
15. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Verhaegen J; Verbist L J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes. Sener B; Köseoglu O Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859 [TBL] [Abstract][Full Text] [Related]
17. Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae. Jones RN; Cormican MG; Wanger A Diagn Microbiol Infect Dis; 1996 Aug; 25(4):201-4. PubMed ID: 8937845 [TBL] [Abstract][Full Text] [Related]
18. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. Liñares J; Perez JL; Garau J; Murgui L; Martín R J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919 [TBL] [Abstract][Full Text] [Related]
19. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313 [TBL] [Abstract][Full Text] [Related]
20. Macrolide resistance in Streptococcus pneumoniae in Hong Kong. Ip M; Lyon DJ; Yung RW; Chan C; Cheng AF Antimicrob Agents Chemother; 2001 May; 45(5):1578-80. PubMed ID: 11302833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]